Shire, Ultragenyx Settle Row Over 'Trade Secret' Doctor List
Two pharmaceutical companies focused on ultra-rare enzyme deficiencies have agreed to settle a dispute over their allegedly dueling access to a handful of American prescribers, attorneys for Shire Pharmaceuticals LLC and...To view the full article, register now.
Already a subscriber? Click here to view full article